These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The role of inflammatory cytokines in diabetic nephropathy. Navarro-González JF; Mora-Fernández C J Am Soc Nephrol; 2008 Mar; 19(3):433-42. PubMed ID: 18256353 [TBL] [Abstract][Full Text] [Related]
3. Diabetic kidney disease and immune modulation. Hickey FB; Martin F Curr Opin Pharmacol; 2013 Aug; 13(4):602-12. PubMed ID: 23721739 [TBL] [Abstract][Full Text] [Related]
4. Role of the adaptive immune system in diabetic kidney disease. Kong L; Andrikopoulos S; MacIsaac RJ; Mackay LK; Nikolic-Paterson DJ; Torkamani N; Zafari N; Marin ECS; Ekinci EI J Diabetes Investig; 2022 Feb; 13(2):213-226. PubMed ID: 34845863 [TBL] [Abstract][Full Text] [Related]
5. The Role of Chemokines and Chemokine Receptors in Diabetic Nephropathy. Chang TT; Chen JW Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32365893 [TBL] [Abstract][Full Text] [Related]
6. New insights into molecular mechanisms of diabetic kidney disease. Badal SS; Danesh FR Am J Kidney Dis; 2014 Feb; 63(2 Suppl 2):S63-83. PubMed ID: 24461730 [TBL] [Abstract][Full Text] [Related]
7. Epigenetic Modifiers as Potential Therapeutic Targets in Diabetic Kidney Disease. Martinez-Moreno JM; Fontecha-Barriuso M; Martin-Sanchez D; Guerrero-Mauvecin J; Goma-Garces E; Fernandez-Fernandez B; Carriazo S; Sanchez-Niño MD; Ramos AM; Ruiz-Ortega M; Ortiz A; Sanz AB Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32526941 [TBL] [Abstract][Full Text] [Related]
8. Renal C3 complement component: feed forward to diabetic kidney disease. Kelly KJ; Liu Y; Zhang J; Dominguez JH Am J Nephrol; 2015; 41(1):48-56. PubMed ID: 25662584 [TBL] [Abstract][Full Text] [Related]
9. Targeting NLRP3 inflammasome as a promising approach for treatment of diabetic nephropathy: Preclinical evidences with therapeutic approaches. Ram C; Jha AK; Ghosh A; Gairola S; Syed AM; Murty US; Naidu VGM; Sahu BD Eur J Pharmacol; 2020 Oct; 885():173503. PubMed ID: 32858047 [TBL] [Abstract][Full Text] [Related]
12. Innate immunity in diabetes and diabetic nephropathy. Wada J; Makino H Nat Rev Nephrol; 2016 Jan; 12(1):13-26. PubMed ID: 26568190 [TBL] [Abstract][Full Text] [Related]
13. The innate immune system in diabetic retinopathy. Pan WW; Lin F; Fort PE Prog Retin Eye Res; 2021 Sep; 84():100940. PubMed ID: 33429059 [TBL] [Abstract][Full Text] [Related]
15. Role of cytokines and chemokines in the regulation of innate immunity and HIV infection. Alfano M; Poli G Mol Immunol; 2005 Feb; 42(2):161-82. PubMed ID: 15488606 [TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-alpha as a therapeutic target for diabetic nephropathy. Navarro-González JF; Jarque A; Muros M; Mora C; García J Cytokine Growth Factor Rev; 2009 Apr; 20(2):165-73. PubMed ID: 19251467 [TBL] [Abstract][Full Text] [Related]
17. The role of the complement system in diabetic nephropathy. Flyvbjerg A Nat Rev Nephrol; 2017 May; 13(5):311-318. PubMed ID: 28262777 [TBL] [Abstract][Full Text] [Related]
18. Diabetes, inflammation, proinflammatory cytokines, and diabetic nephropathy. Navarro JF; Mora C ScientificWorldJournal; 2006 Aug; 6():908-17. PubMed ID: 16906324 [TBL] [Abstract][Full Text] [Related]
19. Diabetic nephropathy - is this an immune disorder? Tesch GH Clin Sci (Lond); 2017 Aug; 131(16):2183-2199. PubMed ID: 28760771 [TBL] [Abstract][Full Text] [Related]